Related Experiment Video

Updated: Mar 23, 2026

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.6K

Comment on "Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for

Yashkumar Kiranbhai Rajvi1, Mohit Kumar2, Dr Shubham Singh3

  • 1Research Scholar, M.Pharm (Pharmaceutics), School of Pharmacy, Rai University, Ahmedabad 382260, Gujarat, India.

Transplantation and Cellular Therapy
|March 21, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CD34+ cell doseHLA mismatchacute myeloid leukemiacord blood transplantationgraft selectionhematopoietic recovery

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

10.2K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.4K

Related Experiment Videos

Last Updated: Mar 23, 2026

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

4.6K
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

10.2K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

13.4K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K

Articles linked to this work by shared authors, journal, and citation graph.

Non-ergosterol lipid remodeling governs amphotericin B susceptibility via TOR-calcineurin signaling in Candida glabrata.

Cell surface (Amsterdam, Netherlands)·2026

Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer's disease mice.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Pathogenesis-Driven Drug Repurposing with a Self-Nanoemulsifying Delivery System for Parkinson's Disease.

Pharmaceuticals (Basel, Switzerland)·2026

Nanomedicine strategies for overcoming multidrug resistance in breast cancer: recent advances and future perspectives.

Journal of the Egyptian National Cancer Institute·2026

Morpho-molecular approach reveals a myco-endophyte, Aspergillus novoparasiticus CBS126849 (MTCC-13997) from the roots of Capparis decidua with therapeutic and enzymatic potential.

Archives of microbiology·2026

Biomedical waste management in veterinary medicine and its impact on the environment: A comprehensive review.

Waste management & research : the journal of the International Solid Wastes and Public Cleansing Association, ISWA·2026

Mutational Landscape and Clonal Dynamics in AML Undergoing PTCy Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026

The Critical Therapeutic Window Lies Before Intubation: HFNC and Mortality Across Ventilatory Escalation Tiers in Pediatric HSCT.

Transplantation and cellular therapy·2026

Integrated analysis of hematopoietic changes following heterochronic bone marrow transplantation between young and aged mice.

Transplantation and cellular therapy·2026

Second Transplantation for Relapsed Hematologic Malignancies After First Allogeneic Hematopoietic Stem Cell Transplantation From an HLA-Matched Related Donor.

Transplantation and cellular therapy·2026

Early gut microbiome metabolites and diversity predict GVHD-free survival after allogeneic hematopoietic cell transplantation.

Transplantation and cellular therapy·2026

Barriers to Patient Referral and Completion of CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma.

Transplantation and cellular therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us